The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $585,096 in first-year total cost, median $585,096.
Most frequent study sections
- Special Emphasis Panel[ZHL1 CSR-C (F1)]1
Most frequent institutions
- RESEARCH INST NATIONWIDE CHILDREN'S HOSP1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | A Study Evaluating the Safety and Efficacy of Second-Generation Tissue Engineered Vascular Grafts (TEVG2)1UG3HL148693-01 | BREUER, CHRISTOPHER KANE | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | $585,096 | ZHL1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.